- Home
- Publications
- Publication Search
- Publication Details
Title
Post-exposure treatments for Ebola and Marburg virus infections
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 17, Issue 6, Pages 413-434
Publisher
Springer Nature
Online
2018-01-29
DOI
10.1038/nrd.2017.251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary Analyses
- (2017) Tao Jiang et al. JOURNAL OF INFECTIOUS DISEASES
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
- (2017) Dustin Siegel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Feng-Cai Zhu et al. LANCET
- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report
- (2017) Gibrilla F. Deen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease
- (2017) John C. Kash et al. Science Translational Medicine
- Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody
- (2017) Chad E. Mire et al. Science Translational Medicine
- A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
- (2017) Angela Huttner et al. Science Translational Medicine
- Ebola virus VP35 blocks stress granule assembly
- (2017) Valerie Le Sage et al. VIROLOGY
- Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
- (2017) I. V. Dolzhikova et al. Human Vaccines & Immunotherapeutics
- Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease
- (2017) Mary-Anne Hartley et al. PLoS Neglected Tropical Diseases
- Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
- (2017) Thi Huyen Tram Nguyen et al. PLoS Neglected Tropical Diseases
- Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Jing-Xin Li et al. Lancet Global Health
- Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial
- (2017) Mandy Kader Konde et al. PLoS One
- Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
- (2017) Logan Banadyga et al. Scientific Reports
- The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus
- (2016) Laura K. McMullan et al. ANTIVIRAL RESEARCH
- Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease
- (2016) Anita K. McElroy et al. CLINICAL INFECTIOUS DISEASES
- Use of Postexposure Prophylaxis After Occupational Exposure toZaire ebolavirus
- (2016) Karen K. Wong et al. CLINICAL INFECTIOUS DISEASES
- Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)—Sierra Leone, 2014
- (2016) Chang-Qing Bai et al. CLINICAL INFECTIOUS DISEASES
- Ebola Virus–Related Encephalitis: Table 1.
- (2016) Thierry de Greslan et al. CLINICAL INFECTIOUS DISEASES
- Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone
- (2016) Amanda Tiffany et al. CLINICAL INFECTIOUS DISEASES
- Ebola virus disease and the eye
- (2016) Jessica G. Shantha et al. CURRENT OPINION IN OPHTHALMOLOGY
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates
- (2016) Shipo Wu et al. JOURNAL OF INFECTIOUS DISEASES
- Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
- (2016) Chad E. Mire et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona
- (2016) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
- (2016) Reed F. Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors: Table 1.
- (2016) Mamadou S. Sow et al. JOURNAL OF INFECTIOUS DISEASES
- Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
- (2016) Chad E. Mire et al. JOURNAL OF INFECTIOUS DISEASES
- The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species ofEbolavirus
- (2016) Robert W. Cross et al. JOURNAL OF INFECTIOUS DISEASES
- Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions
- (2016) Emily V. Nelson et al. JOURNAL OF VIROLOGY
- Late Ebola virus relapse causing meningoencephalitis: a case report
- (2016) Michael Jacobs et al. LANCET
- Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
- (2016) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study
- (2016) John G Mattia et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- Real-time, portable genome sequencing for Ebola surveillance
- (2016) Joshua Quick et al. NATURE
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Neurological Complications of Ebola Virus Infection
- (2016) Bridgette Jeanne Billioux et al. Neurotherapeutics
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
- (2016) Johan van Griensven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Management of Ebola Virus Disease in the United States and Europe
- (2016) Timothy M. Uyeki et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Two-mAb cocktail protects macaques against the Makona variant of Ebola virus
- (2016) Xiangguo Qiu et al. Science Translational Medicine
- Amiodarone and dronedarone: An update
- (2016) Mate Vamos et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques
- (2016) Evan Ewers et al. Viruses-Basel
- Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection
- (2016) C Agrati et al. Cell Death & Disease
- Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins
- (2016) Megan R. Edwards et al. Cell Reports
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques
- (2016) Travis K. Warren et al. PLoS Neglected Tropical Diseases
- Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
- (2016) Ying-Jie Ji et al. Infectious Diseases of Poverty
- Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data
- (2016) Moses J Soka et al. Lancet Global Health
- BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
- (2016) Raymond Taylor et al. Journal of Infection and Public Health
- Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA
- (2016) Emily P. Thi et al. Nature Microbiology
- Experimental Treatment of Ebola Virus Disease with Brincidofovir
- (2016) Jake Dunning et al. PLoS One
- A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever
- (2016) Andrea Marzi et al. Scientific Reports
- Ebola: Perspectives from a Nurse and Patient
- (2015) Will Pooley AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease
- (2015) Diana F. Florescu et al. CLINICAL INFECTIOUS DISEASES
- Clinical Features of Patients With Ebola Virus Disease in Sierra Leone
- (2015) Enqiang Qin et al. CLINICAL INFECTIOUS DISEASES
- Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV–GP Vaccination
- (2015) Lieselotte Cnops et al. CLINICAL INFECTIOUS DISEASES
- The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
- (2015) Colleen S. Kraft et al. CLINICAL INFECTIOUS DISEASES
- Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement
- (2015) Emmanuel Sagui et al. CLINICAL INFECTIOUS DISEASES
- Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States*
- (2015) Viranuj Sueblinvong et al. CRITICAL CARE MEDICINE
- Treating Ebola patients: a ‘bottom up’ approach using generic statins and angiotensin receptor blockers
- (2015) David S. Fedson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick
- (2015) Lilin Lai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses
- (2015) Michelle Meyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Blood kinetics of Ebola virus in survivors and nonsurvivors
- (2015) Simone Lanini et al. JOURNAL OF CLINICAL INVESTIGATION
- Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
- (2015) Marc-Antoine de La Vega et al. JOURNAL OF CLINICAL INVESTIGATION
- Ebola and Marburg haemorrhagic fever
- (2015) V. Rougeron et al. JOURNAL OF CLINICAL VIROLOGY
- Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates
- (2015) Gary Wong et al. JOURNAL OF INFECTIOUS DISEASES
- Immune Response to Marburg Virus Angola Infection in Nonhuman Primates
- (2015) Lisa Fernando et al. JOURNAL OF INFECTIOUS DISEASES
- Modeling the Disease Course ofZaire ebolavirusInfection in the Outbred Guinea Pig
- (2015) Robert W. Cross et al. JOURNAL OF INFECTIOUS DISEASES
- The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014
- (2015) Gabriel Fitzpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease
- (2015) Brian H. Bird et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model
- (2015) Robert W. Cross et al. JOURNAL OF INFECTIOUS DISEASES
- Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.
- (2015) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques
- (2015) Kenny L. Lin et al. JOURNAL OF VIROLOGY
- A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner
- (2015) Alexander Koehler et al. JOURNAL OF VIROLOGY
- Development and Characterization of a Guinea Pig-Adapted Sudan Virus
- (2015) Gary Wong et al. JOURNAL OF VIROLOGY
- Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
- (2015) Edgar Davidson et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care
- (2015) Timo Wolf et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report
- (2015) Manuel Schibler et al. LANCET INFECTIOUS DISEASES
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study
- (2015) Luke Hunt et al. LANCET INFECTIOUS DISEASES
- Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study
- (2015) Danielle V Clark et al. LANCET INFECTIOUS DISEASES
- Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
- (2015) Emily P. Thi et al. NATURE
- Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
- (2015) Chad E. Mire et al. NATURE
- Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus
- (2015) Ilhem Messaoudi et al. NATURE REVIEWS MICROBIOLOGY
- Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
- (2015) Elhadj Ibrahima Bah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Evidence of Sexual Transmission of Ebola Virus
- (2015) Suzanne E. Mate et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence of Ebola Virus in Ocular Fluid during Convalescence
- (2015) Jay B. Varkey et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Von Willebrand Factor Is Elevated in Individuals Infected with Sudan Virus and Is Associated with Adverse Clinical Outcomes
- (2015) Anita K. McElroy et al. VIRAL IMMUNOLOGY
- Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein
- (2015) César G. Albariño et al. VIROLOGY
- A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection
- (2015) Travis K. Warren et al. mBio
- Concerns about the off-licence use of amiodarone for Ebola
- (2015) A. Gupta-Wright et al. BMJ-British Medical Journal
- Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail
- (2015) Jeffrey R. Kugelman et al. Cell Reports
- Prognostic Analysis of Patients with Ebola Virus Disease
- (2015) Xin Zhang et al. PLoS Neglected Tropical Diseases
- Concerns about the off-licence use of amiodarone for Ebola
- (2015) A. Gupta-Wright et al. BMJ-British Medical Journal
- Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process
- (2015) Cristiano Salata et al. Pathogens and Disease
- Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain
- (2015) Marta Mora-Rillo et al. Lancet Respiratory Medicine
- Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles
- (2015) Kelly L. Warfield et al. PLoS One
- Ebola Virus Disease Outbreak in Isiro, Democratic Republic of the Congo, 2012: Signs and Symptoms, Management and Outcomes
- (2015) Thomas Kratz et al. PLoS One
- In VitroEfficacy of Brincidofovir against Variola Virus
- (2014) Victoria A. Olson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
- (2014) Sophie J. Smither et al. ANTIVIRAL RESEARCH
- Reverse genetics systems as tools for the development of novel therapies against filoviruses
- (2014) Thomas Hoenen et al. Expert Review of Anti-Infective Therapy
- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
- (2014) Gerrit Gehring et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome
- (2014) A. K. McElroy et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
- (2014) U. N. Sarwar et al. JOURNAL OF INFECTIOUS DISEASES
- Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
- (2014) Roosecelis Brasil Martines et al. JOURNAL OF PATHOLOGY
- Successful Delivery of RRT in Ebola Virus Disease
- (2014) M. J. Connor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity
- (2014) A. Watt et al. JOURNAL OF VIROLOGY
- Establishment and Characterization of a Lethal Mouse Model for the Angola Strain of Marburg Virus
- (2014) X. Qiu et al. JOURNAL OF VIROLOGY
- A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
- (2014) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Clinical Care of Two Patients with Ebola Virus Disease in the United States
- (2014) G. Marshall Lyon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
- (2014) John S. Schieffelin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
- (2014) Chad E. Mire et al. PLoS One
- Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA
- (2014) E. P. Thi et al. Science Translational Medicine
- Doctors trial amiodarone for Ebola in Sierra Leone
- (2014) F. Turone BMJ-British Medical Journal
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus
- (2013) A. S. Herbert et al. JOURNAL OF VIROLOGY
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Statins as Modulators of Regulatory T-Cell Biology
- (2013) David A. Forero-Peña et al. MEDIATORS OF INFLAMMATION
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
- (2013) Zhinan Jin et al. PLoS One
- Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
- (2013) J. Pettitt et al. Science Translational Medicine
- mAbs and Ad-Vectored IFN- Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms
- (2013) X. Qiu et al. Science Translational Medicine
- Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate
- (2013) César G. Albariño et al. VIROLOGY
- The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells
- (2013) Asuka Nanbo et al. Scientific Reports
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
- (2013) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication
- (2013) Reed S. Shabman et al. PLoS Pathogens
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever
- (2012) Hideki Ebihara et al. JOURNAL OF INFECTIOUS DISEASES
- Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
- (2012) Lauren M. Smith et al. JOURNAL OF INFECTIOUS DISEASES
- Inclusion Bodies Are a Site of Ebolavirus Replication
- (2012) T. Hoenen et al. JOURNAL OF VIROLOGY
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
- (2012) G. G. Olinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques
- (2012) N. A. Twenhafel et al. VETERINARY PATHOLOGY
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
- (2012) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses
- (2011) Thomas Hoenen et al. ANTIVIRAL RESEARCH
- Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus
- (2011) Darryl Falzarano et al. JOURNAL OF INFECTIOUS DISEASES
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Pathogenesis of Marburg Hemorrhagic Fever in Cynomolgus Macaques
- (2011) Lisa E. Hensley et al. JOURNAL OF INFECTIOUS DISEASES
- Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus
- (2011) Hideki Ebihara et al. JOURNAL OF INFECTIOUS DISEASES
- A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA Editing
- (2011) M. Mehedi et al. JOURNAL OF VIROLOGY
- Cathepsin Cleavage Potentiates the Ebola Virus Glycoprotein To Undergo a Subsequent Fusion-Relevant Conformational Change
- (2011) M. Brecher et al. JOURNAL OF VIROLOGY
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
- (2011) Marceline Côté et al. NATURE
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
- (2011) Jan E. Carette et al. NATURE
- T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
- (2011) A. S. Kondratowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EbolavirusVP35 is a multifunctional virulence factor
- (2011) Daisy W. Leung et al. Virulence
- Establishment and application of an infectious virus-like particle system for Marburg virus
- (2010) J. Wenigenrath et al. JOURNAL OF GENERAL VIROLOGY
- Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
- (2010) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Ebola Virus Glycoprotein Counteracts BST-2/Tetherin Restriction in a Sequence-Independent Manner That Does Not Require Tetherin Surface Removal
- (2010) L. A. Lopez et al. JOURNAL OF VIROLOGY
- Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs
- (2010) K. C. Prins et al. JOURNAL OF VIROLOGY
- Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
- (2010) Thomas W Geisbert et al. LANCET
- Therapeutic antibodies, vaccines and antibodyomes
- (2010) Dimiter S. Dimitrov mAbs
- Advanced antisense therapies for postexposure protection against lethal filovirus infections
- (2010) Travis K Warren et al. NATURE MEDICINE
- Aerosol Exposure to the Angola Strain of Marburg Virus Causes Lethal Viral Hemorrhagic Fever in Cynomolgus Macaques
- (2010) D. A. Alves et al. VETERINARY PATHOLOGY
- Establishing Efficacy of Human Products Using Animals
- (2010) P. J. Snoy VETERINARY PATHOLOGY
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
- (2010) Nadia Wauquier et al. PLoS Neglected Tropical Diseases
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
- (2010) Lisa E. Hensley et al. PLoS Pathogens
- Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus
- (2010) Charalampos Valmas et al. PLoS Pathogens
- Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection
- (2009) D. L. Swenson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever
- (2009) K. L. Warfield et al. JOURNAL OF VIROLOGY
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
- (2009) Rachel L. Kaletsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Swine as a Host for the Reston ebolavirus
- (2009) R. W. Barrette et al. SCIENCE
- Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections
- (2008) D. L. Swenson et al. Clinical and Vaccine Immunology
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
- (2008) Dana L Swenson et al. Expert Review of Vaccines
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus
- (2008) A. L. Hartman et al. JOURNAL OF VIROLOGY
- Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
- (2008) Jonathan S. Towner et al. PLoS Pathogens
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started